In conclusion, to our knowledge, this is the first study to explore the co- expression of a lncRNA, AFAP1-AS1, and an immune escape marker, PD-1, in tumor-infiltrating lymphocytes among NPC patients, as well as their synergistic effect on prognosis. Here, AFAP1 is linked to nasopharyngeal carcinoma.